{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T18:18:17Z","timestamp":1788373097746,"version":"build-2803163510"},"update-to":[{"DOI":"10.1371\/journal.pcbi.1014018","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:00:00Z","timestamp":1788307200000}}],"reference-count":65,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T00:00:00Z","timestamp":1787788800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01-CA249229"],"award-info":[{"award-number":["R01-CA249229"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30-CA044579"],"award-info":[{"award-number":["P30-CA044579"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.ploscompbiol.org"],"crossmark-restriction":false},"short-container-title":["PLoS Comput Biol"],"abstract":"<jats:p>Epigenetic dysregulation is a common feature of cancer. It creates vulnerabilities arising from an increased reliance on chromatin-based mechanisms that sustain malignant transcriptional states. While many chromatin regulators are broadly required for cellular viability, others function in a context-dependent manner across distinct oncogenic settings, tissue lineages, and differentiation states. Moreover, chromatin regulators often operate within multi-subunit complexes; thus, epigenetic vulnerabilities emerge from coordinated complex activities. Here, we integrate large-scale genetic dependency maps from human cancer cell lines with curated epigenetic complex annotations to perform a systematic, multivariate analysis of complex-level epigenetic dependencies across cancer lineages. Our analysis reveals that dependencies frequently cluster among functionally related chromatin complexes and that biologically related cancer types (e.g., hematologic malignancies) share similar dependency patterns, consistent with shared underlying epigenetic requirements. Focusing on melanoma, we identify multiple enriched epigenetic complex dependencies, including complexes previously associated with recurrent genetic alterations or melanocyte lineage regulation, as well as a previously unrecognized vulnerability involving the H3K4 methyltransferase complex Set1C\/COMPASS. This dependency is not restricted to a specific melanoma differentiation state, but genetic depletion of CXXC1 (a critical complex-specific subunit) suggests that CXXC1-dependent melanoma cells require Set1C\/COMPASS activity to maintain global H3K4 trimethylation (H3K4me3) and proliferation. Integrative modeling links Set1C\/COMPASS dependency to MYC- and E2F-driven transcriptional programs, which are suppressed upon complex inhibition. Together, this work combines integrative, multivariate analysis of lineage-enriched epigenetic dependencies with genetic perturbation, transcriptional profiling, and single-cell analysis to uncover an enriched epigenetic dependency on Set1C\/COMPASS in melanoma cells.<\/jats:p>","DOI":"10.1371\/journal.pcbi.1014018","type":"journal-article","created":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T17:43:01Z","timestamp":1787852581000},"page":"e1014018","update-policy":"https:\/\/doi.org\/10.1371\/journal.pcbi.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Systematic multivariate analysis of chromatin complex dependencies reveals Set1C\/COMPASS as a melanoma-enriched epigenetic vulnerability"],"prefix":"10.1371","volume":"22","author":[{"given":"Luisa Quesada","family":"Camacho","sequence":"first","affiliation":[{"name":"University of Virginia","place":["Charlottesville, Virginia, United States of America"],"department":["Department of Biomedical Engineering"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0917-3525","authenticated-orcid":true,"given":"Mohammad","family":"Fallahi-Sichani","sequence":"additional","affiliation":[{"name":"University of Virginia","place":["Charlottesville, Virginia, United States of America"],"department":["Department of Biomedical Engineering"]},{"name":"UVA Comprehensive Cancer Center, University of Virginia","place":["Charlottesville, Virginia, United States of America"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,8,27]]},"reference":[{"issue":"8","key":"pcbi.1014018.ref001","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1016\/j.cell.2025.12.049","article-title":"Hallmarks of cancer-then and now, and beyond","volume":"189","author":"D Hanahan","year":"2026","journal-title":"Cell"},{"issue":"6348","key":"pcbi.1014018.ref002","doi-asserted-by":"crossref","DOI":"10.1126\/science.aal2380","article-title":"Epigenetic plasticity and the hallmarks of cancer","volume":"357","author":"WA Flavahan","year":"2017","journal-title":"Science"},{"key":"pcbi.1014018.ref003","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1158\/2159-8290.CD-24-0296","article-title":"The Epigenetic Hallmarks of Cancer","volume":"14","author":"M Esteller","year":"2024","journal-title":"Cancer Discov"},{"issue":"1","key":"pcbi.1014018.ref004","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/s41698-025-01003-7","article-title":"Epigenetic regulators in cancer therapy and progression","volume":"9","author":"HE Marei","year":"2025","journal-title":"NPJ Precis Oncol"},{"issue":"1","key":"pcbi.1014018.ref005","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41392-023-01342-6","article-title":"Epigenetic regulation in hematopoiesis and its implications in the targeted therapy of hematologic malignancies","volume":"8","author":"A Zhao","year":"2023","journal-title":"Signal Transduct Target Ther"},{"issue":"24","key":"pcbi.1014018.ref006","doi-asserted-by":"crossref","first-page":"5449","DOI":"10.1158\/0008-5472.CAN-20-2147","article-title":"EZH2-targeted therapies in cancer: hype or a reality","volume":"80","author":"M-L Eich","year":"2020","journal-title":"Cancer Res"},{"issue":"10","key":"pcbi.1014018.ref007","doi-asserted-by":"crossref","first-page":"7016","DOI":"10.1021\/acs.jmedchem.2c00047","article-title":"Targeting enhancer of zeste homolog 2 for the treatment of hematological malignancies and solid tumors: candidate structure-activity relationships insights and evolution prospects","volume":"65","author":"J Xia","year":"2022","journal-title":"J Med Chem"},{"issue":"5","key":"pcbi.1014018.ref008","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1111\/febs.15750","article-title":"Clinical advances in targeting epigenetics for cancer therapy","volume":"289","author":"S Feng","year":"2022","journal-title":"FEBS J"},{"issue":"3","key":"pcbi.1014018.ref009","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/s41591-019-0376-8","article-title":"Targeting epigenetic modifications in cancer therapy: erasing the roadmap to cancer","volume":"25","author":"HP Mohammad","year":"2019","journal-title":"Nat Med"},{"key":"pcbi.1014018.ref010","doi-asserted-by":"crossref","first-page":"101821","DOI":"10.1016\/j.tranon.2023.101821","article-title":"Epigenetic modifications: Key players in cancer heterogeneity and drug resistance","volume":"39","author":"HQ Sadida","year":"2024","journal-title":"Transl Oncol"},{"issue":"4","key":"pcbi.1014018.ref011","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.celrep.2017.03.078","article-title":"Systematic epigenomic analysis reveals chromatin states associated with melanoma progression","volume":"19","author":"P Fiziev","year":"2017","journal-title":"Cell Rep"},{"issue":"12","key":"pcbi.1014018.ref012","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1038\/s41588-020-00739-1","article-title":"Integrated molecular drivers coordinate biological and clinical states in melanoma","volume":"52","author":"JR Conway","year":"2020","journal-title":"Nat Genet"},{"issue":"6559","key":"pcbi.1014018.ref013","doi-asserted-by":"crossref","DOI":"10.1126\/science.abc1048","article-title":"Developmental chromatin programs determine oncogenic competence in melanoma","volume":"373","author":"A Baggiolini","year":"2021","journal-title":"Science"},{"issue":"1","key":"pcbi.1014018.ref014","doi-asserted-by":"crossref","first-page":"5056","DOI":"10.1038\/s41467-021-25326-8","article-title":"Epigenetic control of melanoma cell invasiveness by the stem cell factor SALL4","volume":"12","author":"J Diener","year":"2021","journal-title":"Nat Commun"},{"issue":"1","key":"pcbi.1014018.ref015","doi-asserted-by":"crossref","first-page":"110637","DOI":"10.1016\/j.celrep.2022.110637","article-title":"Altered BAF occupancy and transcription factor dynamics in PBAF-deficient melanoma","volume":"39","author":"S Carcamo","year":"2022","journal-title":"Cell Rep"},{"issue":"11","key":"pcbi.1014018.ref016","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.1158\/0008-5472.CAN-19-0040","article-title":"HDAC8 regulates a stress response pathway in melanoma to mediate escape from BRAF inhibitor therapy","volume":"79","author":"MF Emmons","year":"2019","journal-title":"Cancer Res"},{"issue":"10","key":"pcbi.1014018.ref017","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.3390\/cancers11101480","article-title":"Epigenetic mechanisms of escape from BRAF oncogene dependency","volume":"11","author":"M Khaliq","year":"2019","journal-title":"Cancers (Basel)"},{"issue":"9","key":"pcbi.1014018.ref018","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1038\/s41556-021-00740-8","article-title":"Human melanocyte development and melanoma dedifferentiation at single-cell resolution","volume":"23","author":"RL Belote","year":"2021","journal-title":"Nat Cell Biol"},{"issue":"5","key":"pcbi.1014018.ref019","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccell.2018.03.017","article-title":"Multi-stage differentiation defines melanoma subtypes with differential vulnerability to drug-induced iron-dependent oxidative stress","volume":"33","author":"J Tsoi","year":"2018","journal-title":"Cancer Cell"},{"issue":"8","key":"pcbi.1014018.ref020","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1038\/s41556-020-0547-3","article-title":"Robust gene expression programs underlie recurrent cell states and phenotype switching in melanoma","volume":"22","author":"J Wouters","year":"2020","journal-title":"Nat Cell Biol"},{"issue":"5","key":"pcbi.1014018.ref021","doi-asserted-by":"crossref","first-page":"111147","DOI":"10.1016\/j.celrep.2022.111147","article-title":"AP-1 transcription factor network explains diverse patterns of cellular plasticity in melanoma cells","volume":"40","author":"N Comandante-Lou","year":"2022","journal-title":"Cell Rep"},{"issue":"1","key":"pcbi.1014018.ref022","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/s41588-020-00749-z","article-title":"Genetic screening for single-cell variability modulators driving therapy resistance","volume":"53","author":"EA Torre","year":"2021","journal-title":"Nat Genet"},{"issue":"1","key":"pcbi.1014018.ref023","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1038\/s41467-021-21784-2","article-title":"Epigenetic modulation reveals differentiation state specificity of oncogene addiction","volume":"12","author":"M Khaliq","year":"2021","journal-title":"Nat Commun"},{"issue":"3","key":"pcbi.1014018.ref024","doi-asserted-by":"crossref","first-page":"109410","DOI":"10.1016\/j.celrep.2021.109410","article-title":"Reprogramming of bivalent chromatin states in NRAS mutant melanoma suggests PRC2 inhibition as a therapeutic strategy","volume":"36","author":"CJ Terranova","year":"2021","journal-title":"Cell Rep"},{"issue":"2","key":"pcbi.1014018.ref025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1007688","article-title":"Phenotype-based probabilistic analysis of heterogeneous responses to cancer drugs and their combination efficacy","volume":"16","author":"N Comandante-Lou","year":"2020","journal-title":"PLoS Comput Biol"},{"issue":"7757","key":"pcbi.1014018.ref026","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/s41586-019-1186-3","article-title":"Next-generation characterization of the Cancer Cell Line Encyclopedia","volume":"569","author":"M Ghandi","year":"2019","journal-title":"Nature"},{"issue":"1","key":"pcbi.1014018.ref027","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1186\/s13059-021-02540-7","article-title":"Chronos: a cell population dynamics model of CRISPR experiments that improves inference of gene fitness effects","volume":"22","author":"JM Dempster","year":"2021","journal-title":"Genome Biol"},{"key":"pcbi.1014018.ref028","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkac989","article-title":"EpiFactors 2022: expansion and enhancement of a curated database of human epigenetic factors and complexes","volume":"51","author":"D Marakulina","year":"2023","journal-title":"Nucleic Acids Res"},{"issue":"7","key":"pcbi.1014018.ref029","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkv007","article-title":"limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"ME Ritchie","year":"2015","journal-title":"Nucleic Acids Res"},{"issue":"20","key":"pcbi.1014018.ref030","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1182\/blood.2023022832","article-title":"BRG1\/BRM inhibitor targets AML stem cells and exerts superior preclinical efficacy combined with BET or menin inhibitor","volume":"143","author":"W Fiskus","year":"2024","journal-title":"Blood"},{"issue":"7","key":"pcbi.1014018.ref031","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1074\/jbc.M116.745398","article-title":"Histone Acetyltransferase p300\/CREB-binding Protein-associated Factor (PCAF) Is Required for All-trans-retinoic Acid-induced Granulocytic Differentiation in Leukemia Cells","volume":"292","author":"Y Sunami","year":"2017","journal-title":"J Biol Chem"},{"issue":"19","key":"pcbi.1014018.ref032","doi-asserted-by":"crossref","first-page":"5527","DOI":"10.1182\/bloodadvances.2020003490","article-title":"MOZ is critical for the development of MOZ\/MLL fusion-induced leukemia through regulation of Hoxa9\/Meis1 expression","volume":"6","author":"T Katsumoto","year":"2022","journal-title":"Blood Adv"},{"issue":"10","key":"pcbi.1014018.ref033","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1101\/gad.1393106","article-title":"MOZ is essential for maintenance of hematopoietic stem cells","volume":"20","author":"T Katsumoto","year":"2006","journal-title":"Genes Dev"},{"issue":"1","key":"pcbi.1014018.ref034","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1158\/2767-9764.CRC-23-0382","article-title":"The ncBAF complex regulates transcription in AML through H3K27ac Sensing by BRD9","volume":"4","author":"DC Klein","year":"2024","journal-title":"Cancer Res Commun"},{"key":"pcbi.1014018.ref035","doi-asserted-by":"crossref","first-page":"2624","DOI":"10.1158\/1078-0432.CCR-20-3463","article-title":"G9a inhibition enhances checkpoint inhibitor blockade response in melanoma","volume":"27","author":"GM Kelly","year":"2021","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res"},{"issue":"10","key":"pcbi.1014018.ref036","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1005555","article-title":"Chromatin-remodelling complex NURF is essential for differentiation of adult melanocyte stem cells","volume":"11","author":"D Koludrovic","year":"2015","journal-title":"PLoS Genet"},{"key":"pcbi.1014018.ref037","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkw377","article-title":"Enrichr: a comprehensive gene set enrichment analysis web server 2016 update","volume":"44","author":"MV Kuleshov","year":"2016","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"pcbi.1014018.ref038","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41576-020-0278-0","article-title":"COMPASS and SWI\/SNF complexes in development and disease","volume":"22","author":"BK Cenik","year":"2021","journal-title":"Nat Rev Genet"},{"issue":"26","key":"pcbi.1014018.ref039","article-title":"Coordinated regulation of cellular identity-associated H3K4me3 breadth by the COMPASS family","volume":"6","author":"CC Sze","year":"2020","journal-title":"Sci Adv"},{"issue":"1","key":"pcbi.1014018.ref040","doi-asserted-by":"crossref","DOI":"10.1016\/j.molcel.2018.05.018","article-title":"Histone methylation by SETD1A protects nascent DNA through the nucleosome chaperone activity of FANCD2","volume":"71","author":"MR Higgs","year":"2018","journal-title":"Mol Cell"},{"issue":"8","key":"pcbi.1014018.ref041","doi-asserted-by":"crossref","first-page":"194578","DOI":"10.1016\/j.bbagrm.2020.194578","article-title":"The role of SETD1A and SETD1B in development and disease","volume":"1863","author":"A Kranz","year":"2020","journal-title":"Biochim Biophys Acta Gene Regul Mech"},{"key":"pcbi.1014018.ref042","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1128\/MCB.01356-07","article-title":"Wdr82 is a C-terminal domain-binding protein that recruits the Setd1A histone H3-lys4 methyltransferase complex to transcription start sites of transcribed human genes","volume":"28","author":"J-H Lee","year":"2008","journal-title":"Mol Cell Biol"},{"issue":"3","key":"pcbi.1014018.ref043","doi-asserted-by":"crossref","first-page":"103190","DOI":"10.1016\/j.xpro.2024.103190","article-title":"Protocol for iterative indirect immunofluorescence imaging in cultured cells, tissue sections, and metaphase chromosome spreads","volume":"5","author":"J Hsu","year":"2024","journal-title":"STAR Protoc"},{"issue":"43","key":"pcbi.1014018.ref044","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"A Subramanian","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"pcbi.1014018.ref045","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"MI Love","year":"2014","journal-title":"Genome Biol"},{"issue":"7","key":"pcbi.1014018.ref046","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1038\/s41375-025-02638-y","article-title":"Regulation of H3K4me3 breadth and MYC expression by the SETD1B catalytic domain in MLL-rearranged leukemia","volume":"39","author":"S Izumi","year":"2025","journal-title":"Leukemia"},{"issue":"1","key":"pcbi.1014018.ref047","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/s41467-023-36150-7","article-title":"Chromatin complex dependencies reveal targeting opportunities in leukemia","volume":"14","author":"FJ Najm","year":"2023","journal-title":"Nat Commun"},{"issue":"4","key":"pcbi.1014018.ref048","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3390\/epigenomes5040023","article-title":"G9a: an emerging epigenetic target for melanoma therapy","volume":"5","author":"JL Flesher","year":"2021","journal-title":"Epigenomes"},{"issue":"2","key":"pcbi.1014018.ref049","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.tcb.2024.06.001","article-title":"Roles of H3K4 methylation in biology and disease","volume":"35","author":"H Wang","year":"2025","journal-title":"Trends Cell Biol"},{"issue":"3","key":"pcbi.1014018.ref050","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.molcel.2017.01.013","article-title":"Not All H3K4 methylations are created equal: Mll2\/COMPASS dependency in primordial germ cell specification","volume":"65","author":"D Hu","year":"2017","journal-title":"Mol Cell"},{"issue":"9","key":"pcbi.1014018.ref051","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1038\/nsmb.2653","article-title":"The Mll2 branch of the COMPASS family regulates bivalent promoters in mouse embryonic stem cells","volume":"20","author":"D Hu","year":"2013","journal-title":"Nat Struct Mol Biol"},{"issue":"22","key":"pcbi.1014018.ref052","doi-asserted-by":"crossref","first-page":"6074","DOI":"10.1128\/MCB.00924-09","article-title":"Global analysis of H3K4 methylation defines MLL family member targets and points to a role for MLL1-mediated H3K4 methylation in the regulation of transcriptional initiation by RNA polymerase II","volume":"29","author":"P Wang","year":"2009","journal-title":"Mol Cell Biol"},{"issue":"23","key":"pcbi.1014018.ref053","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1101\/gad.201327.112","article-title":"Enhancer-associated H3K4 monomethylation by Trithorax-related, the Drosophila homolog of mammalian Mll3\/Mll4","volume":"26","author":"H-M Herz","year":"2012","journal-title":"Genes Dev"},{"issue":"23","key":"pcbi.1014018.ref054","doi-asserted-by":"crossref","first-page":"4745","DOI":"10.1128\/MCB.01181-13","article-title":"The MLL3\/MLL4 branches of the COMPASS family function as major histone H3K4 monomethylases at enhancers","volume":"33","author":"D Hu","year":"2013","journal-title":"Mol Cell Biol"},{"issue":"24","key":"pcbi.1014018.ref055","doi-asserted-by":"crossref","first-page":"7337","DOI":"10.1128\/MCB.00976-08","article-title":"Molecular regulation of H3K4 trimethylation by Wdr82, a component of human Set1\/COMPASS","volume":"28","author":"M Wu","year":"2008","journal-title":"Mol Cell Biol"},{"issue":"6290","key":"pcbi.1014018.ref056","doi-asserted-by":"crossref","DOI":"10.1126\/science.aad9780","article-title":"Epigenetic balance of gene expression by Polycomb and COMPASS families","volume":"352","author":"A Piunti","year":"2016","journal-title":"Science"},{"issue":"18","key":"pcbi.1014018.ref057","doi-asserted-by":"crossref","first-page":"13419","DOI":"10.1074\/jbc.M609809200","article-title":"Identification and characterization of the human Set1B histone H3-Lys4 methyltransferase complex","volume":"282","author":"J-H Lee","year":"2007","journal-title":"J Biol Chem"},{"issue":"9","key":"pcbi.1014018.ref058","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1038\/modpathol.2012.75","article-title":"The role of 8q24 copy number gains and c-MYC expression in amelanotic cutaneous melanoma","volume":"25","author":"P Pouryazdanparast","year":"2012","journal-title":"Mod Pathol"},{"issue":"10","key":"pcbi.1014018.ref059","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1016\/j.celrep.2017.11.022","article-title":"Melanoma Therapeutic Strategies that Select against Resistance by Exploiting MYC-Driven Evolutionary Convergence","volume":"21","author":"KR Singleton","year":"2017","journal-title":"Cell Rep"},{"key":"pcbi.1014018.ref060","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1101\/gad.350078.122","article-title":"Reducing MYC\u2019s transcriptional footprint unveils a good prognostic gene signature in melanoma","volume":"37","author":"MF Zacar\u00edas-Fluck","year":"2023","journal-title":"Genes Dev"},{"issue":"3","key":"pcbi.1014018.ref061","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/s41591-024-02805-1","article-title":"MYC targeting by OMO-103 in solid tumors: a phase 1 trial","volume":"30","author":"E Garralda","year":"2024","journal-title":"Nat Med"},{"issue":"1","key":"pcbi.1014018.ref062","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"A Dobin","year":"2013","journal-title":"Bioinformatics"},{"key":"pcbi.1014018.ref063","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1186\/1471-2105-12-323","article-title":"RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome","volume":"12","author":"B Li","year":"2011","journal-title":"BMC Bioinform"},{"key":"pcbi.1014018.ref064","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/1471-2105-14-128","article-title":"Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool","volume":"14","author":"EY Chen","year":"2013","journal-title":"BMC Bioinformatics"},{"issue":"1","key":"pcbi.1014018.ref065","doi-asserted-by":"crossref","first-page":"289","DOI":"10.32614\/RJ-2016-021","article-title":"mclust 5: clustering, classification and density estimation using Gaussian finite mixture models","volume":"8","author":"L Scrucca","year":"2016","journal-title":"R J"}],"updated-by":[{"DOI":"10.1371\/journal.pcbi.1014018","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:00:00Z","timestamp":1788307200000}}],"container-title":["PLOS Computational Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1014018","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T17:55:30Z","timestamp":1788371730000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1014018"}},"subtitle":[],"editor":[{"given":"Jennifer","family":"Wilson","sequence":"first","affiliation":[{"name":"University of California","place":["UNITED STATES OF AMERICA"]}],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,8,27]]},"references-count":65,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8,27]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pcbi.1014018","relation":{},"ISSN":["1553-7358"],"issn-type":[{"value":"1553-7358","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,27]]}}}